John Wagstaff

John Wagstaff

Swansea University - Swansea / United Kingdom
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1352179
person_outline John Wagstaff's MOST POPULAR ARTICLES
1-) Combined nivolumab and ipilimumab or monotherapy in untreated melanomaJ Larkin, V Chiarion-Sileni, R Gonzalez, JJ Grob, CL Cowey, CD Lao, ...New England journal of medicine 373 (1), 23-34, 201568242015
2-) Nivolumab versus everolimus in advanced renal-cell carcinomaRJ Motzer, B Escudier, DF McDermott, S George, HJ Hammers, S Srinivas, ...New England Journal of Medicine 373 (19), 1803-1813, 201551822015
3-) Overall survival with combined nivolumab and ipilimumab in advanced melanomaJD Wolchok, V Chiarion-Sileni, R Gonzalez, P Rutkowski, JJ Grob, ...New England Journal of Medicine 377 (14), 1345-1356, 201728542017
4-) Five-year survival with combined nivolumab and ipilimumab in advanced melanomaJ Larkin, V Chiarion-Sileni, R Gonzalez, JJ Grob, P Rutkowski, CD Lao, ...New England journal of medicine 381 (16), 1535-1546, 201933472019
5-) Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trialCN Sternberg, ID Davis, J Mardiak, C Szczylik, E Lee, J Wagstaff, ...Journal of clinical oncology 28 (6), 1061-1068, 201030672010